NCT00595465View on ClinicalTrials.gov

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

PHASE3CompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

June 30, 2008

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

Japanese Encephalitis purified inactivated vaccine

IC51 6 mcg i.m. injection on Day 0 and Day 28

Trial Locations (4)

1090

Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie, Vienna

10117

Berliner Zentrum Reise- und Tropenmedizin, Berlin

18057

Klinik und Poliklinik für Innere Medizin der Universität Rostock, Rostock

80802

Klinikum der Universität München, Abteilung für Infektions- und Tropenmedizin, Munich

All Listed Sponsors
lead

Valneva Austria GmbH

INDUSTRY

NCT00595465 - Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 | Biotech Hunter | Biotech Hunter